Age-related changes in neuroactive steroid levels in 3xTg-AD mice

Abstract Although neuroactive steroids exert neuroprotective actions in different experimental models of neurodegenerative diseases, including those of Alzheimer's disease (AD), their relationships with aged related physiologic and pathologic brain changes remain to be clarified. In this study...

Full description

Saved in:
Bibliographic Details
Published inNeurobiology of aging Vol. 34; no. 4; pp. 1080 - 1089
Main Authors Caruso, Donatella, Barron, Anna M, Brown, Meghan A, Abbiati, Federico, Carrero, Paloma, Pike, Christian J, Garcia-Segura, Luis M, Melcangi, Roberto C
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.04.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Although neuroactive steroids exert neuroprotective actions in different experimental models of neurodegenerative diseases, including those of Alzheimer's disease (AD), their relationships with aged related physiologic and pathologic brain changes remain to be clarified. In this study the levels of pregnenolone, dehydroepiandrosterone, progesterone, dihydroprogesterone, tetrahydroprogesterone, isopregnanolone, testosterone, dihydrotestosterone, 5α-androstane-3α,17β-diol, 5α-androstane-3β,17β-diol, 17α-estradiol, and 17β-estradiol were assessed in the limbic region of young adult (7 months) and aged (24 months) male wild type and triple transgenic AD mice. Age related neuropathological changes in AD brains, such as β-amyloid accumulation and gliosis, were associated with modified levels of specific neuroactive steroids and particularly with changes in the levels of progesterone and testosterone metabolites. The altered levels of neuroactive steroids in aged AD brains might impact on the activation of neuroprotective signaling mediated by classic and nonclassic steroid receptors, like the gamma-aminobuttyric acid (GABA)-A receptor.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
These two authors contributed equally to this work
ISSN:0197-4580
1558-1497
DOI:10.1016/j.neurobiolaging.2012.10.007